v3.26.1
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Dec. 14, 2023
May 16, 2022
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
May 16, 2025
Nov. 27, 2023
Nov. 26, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Share price                 $ 1.00 $ 1.00  
Reverse stock split 1-for-5                    
Preferred stock, shares authorized       50,000,000   50,000,000   50,000,000   50,000,000 10,000,000
Preferred stock, shares issued       0   0   0      
Preferred stock, shares outstanding       0   0   0      
Common stock shares, issued       8,544,073   8,544,073   6,982,675      
Common stock shares outstanding       7,384,073   7,384,073   5,822,675      
Warrants exercised           0          
Placement Agent Warrant [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrant issued       4,125   4,125          
Exercise price       $ 41.25   $ 41.25          
Warrants contractual term       5 years   5 years          
Fair value of warrants           $ 21,479          
Private Warrant [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Warrants contractual term       5 years   5 years          
Warrant expiration       Aug. 08, 2027   Aug. 08, 2027          
Common Stock [Member]                      
Accumulated Other Comprehensive Income (Loss) [Line Items]                      
Reverse stock split 1-for-5 1-for-5 1-for-15                
Number of additional shares issued for settlement           1,561,398          
Issuance of common stock from at-the-market offering, shares         256,502 283,336 262,383        
Issuance of stock to settle vested RSUs, shares       1,239,000 540,000 1,239,000 541,174        
Issuance of common stock for consulting services, shares       39,062 28,555 39,062 28,555